On May 7, the 6th event of "Online Foreign Exchange Investment for Early Projects" came to a successful conclusion. The holding of multiple consecutive periods of foreign investment creation gave more opportunities for high-quality projects to be displayed, and also gave investme

html On May 7th, the sixth event of "Early Project Online Chuanghuihui" was successfully concluded. The holding of multiple consecutive phases of Chuanghuihui gave more opportunities to showcase high-quality projects, and also gave investment institutions in the track a More efficient channels. This event is under the guidance of the Nanhu New District Management Committee of Jiaxing City and co-sponsored by Nanhu Fund Town (Investment and Finance Circle) and Beituo Capital, with full support from ecosystem partners. Through a one-to-many online video roadshow format, we can effectively connect startups with professional leading institutions in the industry, solve their financing needs during growth and development, and help outstanding companies grow better and live better!

This event is fully supported by A-round Academy and Star Capital as strategic partners. Six outstanding companies have been carefully selected to participate in the event, namely: Gongxin Internet, Kezhida, Wei Zhi Technology, and Qingying Vision , Hujiang Technology and Inven Technology are high-quality potential companies involved in corporate services, biomedicine, medical health, intelligent manufacturing and other industries.

Precision Investment

In the past 3 weeks, "Early Project Online Innovation" has been successfully held for 6 sessions, successfully serving companies from technological innovation, medical health, artificial intelligence, intelligent manufacturing, big data cloud computing, and enterprises Excellent companies in many fields such as new energy and new materials provide communication channels to accurately reach investors, shorten the distance between entrepreneurial projects and investment institutions, and effectively accelerate the project financing process and success rate, helping more than 30 entrepreneurial companies. Benefit.

Review of the Chuanghui Project in this issue

1. Gongxin Internet

" supply chain finance SaaS service platform" based on trusted data

Company introduction: Gongxin Internet was established in 2018. The company focuses on Supply chain finance for fast-moving goods, logistics, and medical companies focuses on core companies to serve their upstream and downstream companies. Based on the core company's historical order data, it unifies the data interface to save core company system development costs, and introduces multiple investors to provide core companies with Comprehensive financial services provide dealers and suppliers of core enterprises with appropriate, efficient and convenient loan services to help core enterprises grow sales and expand market share.

project highlights

1. Focus on core enterprises to serve their upstream and downstream enterprises, aggregating core enterprise internal management data, external sales SaaS software data, and third-party credit data to provide financial institutions with real, credible, and real-time operating data. , assisting financial institutions to acquire customers accurately; showing financial institutions the real information flow, logistics and capital flow data of logistics companies, and jointly developing structured combined financial products based on digital assets in the logistics supply chain. Create a new financial model for the supply chain financial industry through logistics enterprise data;

2. Core enterprises that have signed contracts and are currently signing contracts: Budweiser Beer, Jinmailang, Xiwang Food, Wudeli Flour Group, Double Star Tire, Changshouhua , Jinsha River Noodle Industry, Good Neighbor, Aishide , Wrigley Home Furnishing, Pechoin;

3. From June 2019 to now, the credit scale has exceeded 1.4 billion, and currently, 150 million to 200 million new credits are added every month.

2. Kezhida

is a high-tech enterprise integrating the research and development, production and sales of new diagnostic reagents and precision instruments.

Company introduction: Wuxi Kezhida gathers biomedicine, polymer materials, structural engineering, precision optics, Excellent talents in the fields of electronic technology, intelligent collaborative manufacturing and application, focusing on the application of microfluidic technology, artificial intelligence and other technologies in medical testing, animal diseases, food safety and other fields. After years of painstaking research, they have broken through many industry technical bottlenecks. , developed a number of new products with independent intellectual property rights and core competitiveness.

project highlights

1. Opening up the blue ocean market for molecular testing: the fully automatic pathogenic microorganism nucleic acid detection system integrates extraction, amplification and detection, and is fully automated (1 minute of manual operation, and all detection processes are completed within 60 minutes). Breaking through the limitations of existing detection technology on personnel/places, the advantages of distributed deployment can be applied in multiple scenarios to promote diagnosis forward and downward;

2. Accurate diagnosis: One sample detects 21 indicators at the same time, which is conducive to the accurate identification of pathogens with similar symptoms. Diagnosis and early detection of mixed infections, high accuracy, avoid missed detection, more in line with the needs of clinical testing;

3. Wide application fields: testing reagents cover medical and health, animal diseases, food safety testing and other subdivisions, with broad prospects;

4. The company has achieved profitability, with sales in 2019 reaching more than 20 million yuan.

3. Wei Zhi Technology

A dynamic and rapidly developing biotechnology company

Company introduction: Wei Zhi Technology was founded in 2013 as a scientific research reagent brand St John's Laboratory in London, England. In the early stage of its development, it mainly focused on Europe and the United States. Market, the target customer groups are hospitals, universities, pharmaceutical companies, etc. After 7 years of development, the company now has a mature scientific research antibody IVD product system, a mature B2B scientific research e-commerce platform and a good market reputation. The company's core development goal is to help scientific researchers find the most suitable scientific research reagents and solve the problem of inconsistent industry quality standards. At present, the company has grown into an independent third party in the industry - a leading enterprise in the field of antibody verification.

company development history:

In 2014, in order to solve the problem of inconsistent industry quality standards, the "Antibody Verification Plan" was established to build a new decentralized quality standard through cooperation with scientific researchers;

In 2015, the Antibody Verification Plan Recognized in articles in nature science magazine;

In 2016, the company signed a contract to become the official cooperative supplier of neupc, the Northeastern University Purchasing Alliance in the UK, and directly supplied scientific research reagents to 22 alliance universities;

In 2017, the company was officially registered in Shanghai with Wei Zhi Technology, Explore the application of big data in the field of biological research;

will participate in the China International Import Expo in 2018 and display the latest scientific and technological achievements at the National Technology Transfer Eastern Center for a period of one year;

products will officially enter the domestic market in 2019.

project highlights

1. As of now, it has accumulated more than 5,000 antibody verification reports. In the future, it will build a multi-dimensional and highly time-effective antibody database to help scientific research users reduce the risk of experimental failure and establish a decentralized quality standard system;

2. At present, it has 50+ dealers around the world, covering more than 80% of the world's major markets, with stable cash flow and a healthy and sustainable development model;

3. The core team is mainly composed of returned overseas students, and all members have 10 years in the field of biotechnology The above work experience.

4. Qingying Vision

is a visual technology company that independently develops "universal three-dimensional instant imaging technology" with unique principles and performance.

Company introduction: Qingying machine vision company was established in 2016 and is a national high-tech company. The company is also the 2019 Zhongguancun gold seed company. Its fully independently developed matrix camera is the only one in the field of three-dimensional machine vision that can adapt to various lighting conditions, long distance, large scenes, high speed, high precision, and embedded chip algorithm, purely optical passive 3D camera. Starting from the invention of basic principles, the company took four years to successfully develop a full set of matrix camera three-dimensional imaging technology and three-dimensional matrix camera products. It has obtained 8 Chinese invention patents and 8 invention patents each from the United States, Japan, the European Union, and South Korea. It is currently in the power grid. , forging, casting, railways, unmanned mines, logistics and other scenarios have begun to be fully promoted and applied.

project highlights

1. Fully independent innovation: comprehensive innovation from principles, camera hardware, three-dimensional algorithms, FPGA embedded chip algorithms, application systems, etc. All software is compiled based on the underlying C language, which is fundamental and fundamental in the field of three-dimensional machine vision perception. Platform-based innovative technology;

2. Unique technical features: different from any existing three-dimensional technology means, able to solve many problems that cannot be solved by existing technologies;

3. Extremely high technical barriers: comprehensive patent coverage, global layout, chips 3D algorithm, obvious hardware features;

4. The market is in urgent need: the current applications are concentrated in large scenes, high dynamics, and high-precision industrial online measurement. These applications are urgently needed by users and the current technology cannot meet the needs. The market scale is large. High user acceptance and easy promotion;

5. Brand new track, broad application prospects: It has broad application prospects, huge room for technological growth, and huge market imagination;

6. Excellent entrepreneurial team: the team has many years of experience Cooperate and start a business together. We have been working together in the field of machine vision for 20 years. We have rich entrepreneurial experience and a deep understanding of application requirements and application environments.

5. Hujiang Technology

VR virtual simulation medical training system service provider

Company introduction: Hujiang Technology was established in 2019. The company team was initiated by VR experts and medical experts from China, France and the United States, and is committed to improving The professional skills of medical students and medical staff continue to provide users with professional medical training in various real-life scenarios through VR simulation systems.

project highlights

company's VR medical training has the characteristics of interactivity, authenticity, professionalism, and high simulation:

1. Users can train in a short time, high frequency, and immersively, and the learning effect is better than traditional The method is more efficient; 2. Users can learn professional medical knowledge in non-first-tier cities without geographical restrictions, and better share educational resources; 3. Artificial intelligence coaches can provide personalized training for doctors, nurses, medical students, etc. ; 4. Low cost, simple deployment, no waste of tight medical resources, and broad market application prospects; 5. Medical personnel can conduct interactive training on a global scale (multi-person network environment) and quickly update medical knowledge; 6. Already The Chinese University of Hong Kong School of Medicine develops advanced life support, venous blood collection and other modules; 7. It has become a 5G application demonstration base for Zhuhai Unicom; 8. It has conducted special VR training on first aid and advanced life support for Hong Kong Elizabeth Hospital.

6. Inven Technology

helps improve radiotherapy imaging and treatment of lung cancer/ liver cancer /breast cancer

Company introduction: Inven Technology is registered in Australia. The company provides better tumor targeting and patient respiratory and The personalized management of tumor motion induced by cardiac motion has improved radiotherapy imaging and treatment of lung cancer/liver cancer/breast cancer. The four-dimensional MRI and magnetic resonance accelerator developed by it have now become the latest technology in radiotherapy treatment of cancer. Due to the existence of strong magnetic fields, traditional quality assurance systems and equipment are no longer applicable. The dynamic phantom invented by Inven Technology has filled this much-needed international gap. ChestPhan-4DMRI is the latest quality-assured medical device available for four-dimensional MRI and magnetic resonance accelerators.

project highlights

1. Yinwen Technology has 1 invention, 1 international patent, 6 national invention patents (Chinese, British, German, French, Australian and American);

2. Unique technology: ahead of all deformable, Similar to human chest and other chest organs, there are currently no direct competitors;

3. The company currently has purchase intention orders.